News Search Results
Oct 20, 2025, 15:00 ET Warner Bros. Discovery to Report Third Quarter 2025 Results on Thursday, November 6
inspires, informs and entertains audiences worldwide through its iconic brands and products including: Discovery Channel, HBO Max, discovery+, CNN, DC, TNT Sports, Eurosport, HBO, HGTV, Food Network, OWN, Investigation Discovery, TLC, Magnolia Network, TNT, TBS, truTV, Travel Channel, Animal Planet,
More news about: Warner Bros. Discovery, Inc.
Oct 20, 2025, 12:58 ET Jiuzi Holdings, Inc. geht strategische Partnerschaft mit BitFi ein, um Bitcoin-zentrierte Finanzdienstleistungen voranzutreiben
Ladeinfrastruktur für Fahrzeuge mit neuen Energien in Chinas Städten der dritten und vierten Ebene. Das Unternehmen konzentriert sich auf leistungsstarke DC-Schnellladestationen mit integrierten Energiespeichermöglichkeiten. Weitere Informationen finden Sie auf jzxn.com.
More news about: Jiuzi Holdings, Inc
Oct 20, 2025, 12:38 ET Jiuzi Holdings, Inc. gaat een strategisch partnerschap met BitFi aan om Bitcoin-gerichte financiering te bevorderen
van intelligente laadinfrastructuur voor voertuigen op nieuwe energie in derde- en vierdegraads steden in China. Het bedrijf richt zich op krachtige DC-snellaadstations geïntegreerd met energieopslagmogelijkheden. Meer informatie: jzxn.com.
More news about: Jiuzi Holdings, Inc
Oct 20, 2025, 12:06 ET City First Bank Appoints Justin Jennings as Executive Vice President, Chief Deposit Officer
National Association, is pleased to announce the appointment of Justin Jennings as Executive Vice President, Chief Deposit Officer, based in Washington, DC. In this role, Jennings will lead treasury management services, banking operations, digital banking, and deposit strategy. He will report directly to
More news about: Broadway Financial Corporation
Oct 20, 2025, 11:01 ET NumberSquad Launches Year‑Round Tax Planning Package for Small Businesses and the Self‑Employed
tax and accounting professionals has supported hundreds of clients locally and remotely, with a focus on the Washington, DC metro area including, Northern Virginia and Maryland. Tech-enabled and client-focused, NumberSquad builds tools like DocuPort
More news about: taxnews.numbersquad.com
Oct 20, 2025, 11:00 ET UNIVERSITY OF MARYLAND, BALTIMORE AND AXIS RESEARCH & TECHNOLOGIES ANNOUNCE JOINT VENTURE TO BUILD NATION'S FIRST AI-POWERED SMART SURGICAL PERFORMANCE CENTER
student trainees and over 3,000 faculty members, including notable members of the National Academy of Medicine. As the largest public medical school in the DC/MD/VA region, faculty-physicians are working to help patients manage chronic diseases like obesity, cancer, heart disease and addiction, while also working
More news about: University of Maryland School of Medicine
Oct 20, 2025, 10:56 ET Arelion strengthens Baltic connectivity with new resilient route, reducing latency to Western Europe
Greenergy's Tallinn DC-1 PoP in Hüüru, Estonia
More news about: Arelion
Oct 20, 2025, 09:38 ET 엑스피펜, 혁신적 신제품 'Artist 12 3rd' 공개...X-Dial 단축키와 업그레이드된 X4 스마트 칩 스타일러스 탑재
디스플레이는 AG 나노 에칭 글래스(AG nano-etched glass)와 AF 코팅(Anti-Fingerprint coating)으로 제작돼, 종이 질감의 자연스러운 필기감을 제공하며, 눈부심, 긁힘, 지문에 강해 몰입감 있는 드로잉 환경을 제공한다. 또한 DC 디밍(DC Dimming) 기능이 주변 밝기에 맞춰 자동으로 조절해, 장시간 창작 활동 시에도 시각적 편안함을 제공하고 눈을 보호한다. 편의성을 높이기 위해 접이식 스탠드가 포함되어 원하는 시야각으로 쉽게 조절할 수 있으며, 풀 기능 USB-C 케이블은 단일 케이블
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 09:38 ET XPPen Unveils Stunning New Artist 12 3rd with X-Dial Shortcut Keys and Upgraded X4 Smart Chip Stylus
provides a natural, paper-like texture that effectively resists glare, scratches, and fingerprints for an immersive drawing experience. Furthermore, DC dimming automatically adjusts brightness based on ambient lighting, a feature meticulously designed for visual comfort and eye care during extended creative
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 09:38 ET XPPen Unveils Stunning New Artist 12 3rd with X-Dial Shortcut Keys and Upgraded X4 Smart Chip Stylus
provides a natural, paper-like texture that effectively resists glare, scratches, and fingerprints for an immersive drawing experience. Furthermore, DC dimming automatically adjusts brightness based on ambient lighting, a feature meticulously designed for visual comfort and eye care during extended creative
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 09:38 ET XPPen enthüllt das neue Artist 12 3rd mit X-Dial-Schnelltasten und verbessertem X4 Smart Chip Stylus
papierähnliche Textur, die Blendungen, Kratzern und Fingerabdrücken wirksam widersteht und so für ein intensives Zeichenerlebnis sorgt. Darüber hinaus passt die DC-Dimmung die Helligkeit automatisch an die Umgebungsbeleuchtung an. Diese Funktion wurde sorgfältig entwickelt, um auch bei längeren kreativen Sitzungen
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 09:38 ET XPPen apresenta a nova e impressionante Artist 12 3rd com teclas de atalho X-Dial e caneta stylus com chip inteligente X4 aperfeiçoada
que resiste efetivamente ao brilho, arranhões e impressões digitais que proporcionam uma experiência de desenho imersiva. Além disso, o escurecimento DC ajusta automaticamente o brilho com base na iluminação ambiente, um recurso meticulosamente projetado para conforto visual e cuidados com os olhos durante
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 09:38 ET XPPen presenta el nuevo y sorprendente Artist 12 3rd con teclas de acceso directo X-Dial
similar al papel que resiste eficazmente el reflejo, los arañazos y las huellas dactilares para una experiencia de dibujo inmersiva. Además, la atenuación DC ajusta automáticamente el brillo según la luz ambiental, una función diseñada meticulosamente para la comodidad visual y el cuidado de los ojos durante
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 09:38 ET XPPen dévoile l'étonnant nouvel Artist 12 3rd doté des touches de raccourci X-Dial et du stylet à puce intelligente X4 amélioré
celle du papier qui résiste efficacement aux reflets, aux rayures et aux traces de doigts pour une expérience de dessin immersive. De plus, la gradation DC ajuste automatiquement la luminosité en fonction de l'éclairage ambiant, une fonction méticuleusement conçue pour le confort visuel et le soin des yeux
More news about: XPPen Technology Co., Ltd.
Oct 20, 2025, 08:35 ET Locksley Unveils First 100% American Made Antimony Ingot
validating a 100% American made mine-to-metal supply chain that advance U.S. national objectives ahead of Australia and United States Meetings in Washington DC this week SAN BERNARDINO, Calif.,
More news about: Locksley Resources
Oct 20, 2025, 08:00 ET Lower mortgage rates extend housing momentum into fall
Washington, DC
More news about: Zillow
Oct 20, 2025, 07:15 ET Jiuzi Holdings, Inc Enters Strategic Partnership with BitFi to Advance Bitcoin-Centric Finance
leading provider of intelligent charging infrastructure for new energy vehicles in China's third- and fourth-tier cities. The company focuses on high-power DC fast charging stations integrated with energy storage capabilities. For more information, please visit jzxn.com.
More news about: Jiuzi Holdings, Inc
Oct 20, 2025, 07:15 ET Jiuzi Holdings, Inc Enters Strategic Partnership with BitFi to Advance Bitcoin-Centric Finance
leading provider of intelligent charging infrastructure for new energy vehicles in China's third- and fourth-tier cities. The company focuses on high-power DC fast charging stations integrated with energy storage capabilities. For more information, please visit jzxn.com.
More news about: Jiuzi Holdings, Inc
Oct 20, 2025, 07:00 ET Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025
Jersey and employs over 10,000 people throughout the country across 12 manufacturing, R&D and corporate locations in eight states plus Washington DC. For more information, visit
More news about: NOVO NORDISK INC.
Oct 20, 2025, 07:00 ET Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025
Jersey and employs over 10,000 people throughout the country across 12 manufacturing, R&D and corporate locations in eight states plus Washington DC. For more information, visit
More news about: NOVO NORDISK INC.
Oct 20, 2025, 04:57 ET The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
the clinical stage. The company has established one of the world's leading proprietary ADC and novel DC platforms, OptiDC™, and has 2 ADC projects approved for marketing, and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 20, 2025, 01:44 ET Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
the clinical stage. The company has established one of the world's leading proprietary ADC and novel DC platforms, OptiDC™, and has 1 ADC project approved for marketing and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 19, 2025, 22:01 ET Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
the clinical stage. The company has established one of the world's leading proprietary ADC and novel DC platforms, OptiDC™, and has 2 ADC project approved for marketing and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 18, 2025, 10:42 ET Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
the clinical stage. The company has established one of the world's leading proprietary ADC and novel DC platforms, OptiDC™, and has 2 ADC project approved for marketing and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 17, 2025, 17:39 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
Jersey and employs over 10,000 people throughout the country across 12 manufacturing, R&D and corporate locations in eight states plus Washington DC. For more information, visit
More news about: Novo Nordisk